FASEB SUMMER RESEARCH CONFERENCE ON RETINOIDS

此应用程序请求部分支持1990年的FASE B夏季 维甲酸研究会议。本次会议计划召开 1990年6月17日至22日，在佛蒙特州萨顿河的佛蒙特州学院。1990年 这次会议将是关于这一主题的第五次FASEB两年一次的会议。这个 前四次会议分别于1982年6月、1984年、1986年和1988年举行，均为 从出席人数众多、对……的明显热情来看，非常成功 提出的主题，以及认识到真正的重大进展是 完成了。 在过去的十年里，维甲酸的研究领域已经扩大到包括 科学家来自不同领域，从营养、癌症预防、 眼科、皮肤科、畸形科、新陈代谢、分化和 发展，以及分子和细胞生物学。1990年代的主要范围 FASEB关于维甲酸的夏季会议将提供一个共同的论坛来 来自不同国家和背景的科学家了解 维甲酸研究的最新进展，并与 同事们。这对年轻的研究人员来说尤其重要，他们是 希望为他们的未来找到高效和刺激的环境 努力。会议将提供一个海报讨论会议，以 最大限度地提高年轻研究人员的积极参与。 此外，大会还将分成八个平台 将包括以下主要领域的会议：选定的方面 关于实地方法和在根除疟疾方面的主要成就 维生素A缺乏症；血浆和细胞维甲酸结合蛋白； 维甲酸与细胞通讯、发育和分化 在眼睛中；视黄酸受体和基因表达的控制；以及 疾病状态中的维甲酸，包括肿瘤发生、皮肤病和 畸形症。因此，该方案包括以下重点研究领域： 基础和临床科学家以及对 可能适用于实地情况的新的基本方面。它是 我认为，会议传统上的成功在一定程度上是由于 它为在不同领域工作的研究人员提供了机会 在一个非正式的环境中聚在一起一周，讨论关注的问题和 想出新点子。过去关于维甲酸的会议可能是 该领域蓬勃发展、前景看好的原因 事态的发展。

This application requests partial support for the 1990 FASEB Summer Research Conference on Retinoids. This conference is scheduled to be held June 17-22, 1990, at the Vermont Academy in Sarton's River, VT. The 1990 conference will be the fifth biennial FASEB conference on this topic. The four previous conferences, held in June 1982, 1984, 1986 and 1988, were all highly successful as judged by a large attendance, evident enthusiasm for the topics presented, and a realization that real major advances had been accomplished. The field of retinoid research has expanded in the last decade to include scientists from areas as diverse as nutrition, cancer prevention, ophthalmology, dermatology, teratology, metabolism, differentiation and development, and molecular and cell biology. The major scope of the 1990 FASEB Summer Conference on Retinoids is to provide a common forum to scientists from different countries and backgrounds to learn about the latest developments in retinoid research and share their ideas with colleagues. This is particularly important for younger researchers who are looking to find productive and stimulating environments for their future endeavors. The conference will provide a poster discussion session to maximize active participation by younger researchers. In addition, the conference will be articulated into eight platform sessions which will comprise the following major areas: selected aspects of field methodology and major accomplishments in the eradication of vitamin A deficiency; plasma and cellular retinoid binding proteins; retinoids in cell communication, development and differentiation; retinoids in the eye; the retinoic acid receptors and control of gene expression; and retinoids in disease states including tumorigenesis, skin diseases and teratogenesis. This program, therefore, includes focal research areas for both basic and clinical scientists as well as for specialists interested in novel basic aspects which might be applied to the field situation. It is felt that the traditional success of the conference is in part due to the opportunity it has afforded researchers working in diverse areas to get together for a week in an informal setting to discuss points of concern and to come up with new ideas. The past conferences on retinoids may be one of the reasons why the field is vigorous and promising of exciting future developments.